- Home
- ABSI vs GMRE Comparison
ABSI vs GMRE Comparison
Compare ABSI & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- GMRE
- Stock Information
- Founded
- ABSI 2011
- GMRE 2011
- Country
- ABSI United States
- GMRE United States
- Employees
- ABSI N/A
- GMRE N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- GMRE Real Estate Investment Trusts
- Sector
- ABSI Health Care
- GMRE Real Estate
- Exchange
- ABSI Nasdaq
- GMRE Nasdaq
- Market Cap
- ABSI 457.6M
- GMRE 525.1M
- IPO Year
- ABSI 2021
- GMRE N/A
- Fundamental
- Price
- ABSI $3.01
- GMRE $7.87
- Analyst Decision
- ABSI Strong Buy
- GMRE Strong Buy
- Analyst Count
- ABSI 6
- GMRE 2
- Target Price
- ABSI $8.67
- GMRE $10.88
- AVG Volume (30 Days)
- ABSI 2.4M
- GMRE 480.0K
- Earning Date
- ABSI 11-12-2024
- GMRE 11-06-2024
- Dividend Yield
- ABSI N/A
- GMRE 10.67%
- EPS Growth
- ABSI N/A
- GMRE N/A
- EPS
- ABSI N/A
- GMRE N/A
- Revenue
- ABSI $4,207,000.00
- GMRE $136,585,000.00
- Revenue This Year
- ABSI $8.57
- GMRE N/A
- Revenue Next Year
- ABSI $169.72
- GMRE $5.48
- P/E Ratio
- ABSI N/A
- GMRE N/A
- Revenue Growth
- ABSI N/A
- GMRE N/A
- 52 Week Low
- ABSI $2.45
- GMRE $7.68
- 52 Week High
- ABSI $6.72
- GMRE $11.46
- Technical
- Relative Strength Index (RSI)
- ABSI 44.56
- GMRE 23.72
- Support Level
- ABSI $2.79
- GMRE $7.68
- Resistance Level
- ABSI $4.11
- GMRE $8.58
- Average True Range (ATR)
- ABSI 0.42
- GMRE 0.20
- MACD
- ABSI -0.04
- GMRE -0.06
- Stochastic Oscillator
- ABSI 12.28
- GMRE 17.59
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.